Gliogene: A Familial Brain Tumor Study

 

Gliogene Largest Genetic Study of Glioma in Families

"I have been researching familial glioma for nearly 30 years and our team has already identified one gene, POT1, in some glioma families. With this new, larger study, and with your help, we will be able to identify more genes in families with brain cancer." - Melissa Bondy, Ph.D., Gliogene Principal Investigator

Pursuing the Link Between Brain Cancer and Genes

In the United States, 23,720 people are diagnosed every year with a malignant primary brain tumor, known as a glioma. Of these cases, 5 to 10 percent are believed to run in families. Gliogene is the largest genetic study of glioma in families and aims to reveal more about genes that may contribute to brain tumors. If you and a blood-relative were both diagnosed with glioma, you may be eligible to participate in Gliogene.

Read more about Gliogene
Participate

If you and a blood-relative were both diagnosed with glioma, you may be eligible to participate.

Impact

Read the academic publications arising from Gliogene

Resources

Living with a brain tumor can be overwhelming, and it can be difficult to find the help you need. We've collected these resources from our partners to help.

News

Stay abreast of media stories about Gliogene research and activity. 

Gliogene

  • Department of Epidemiology & Population Health (E&PH)
  • 150 Governor's Lane
    HRP Redwood Building
    Stanford University School of Medicine
    Stanford, California 94305-5405

Contact Us